|Bid||1.40 x 200|
|Ask||3.89 x 600|
|Day's Range||3.10 - 3.19|
|52 Week Range||2.41 - 7.39|
|PE Ratio (TTM)||-0.72|
|Earnings Date||Sep 18, 2017 - Sep 22, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
RANCHO CORDOVA, Calif., June 23, 2017-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, is set to join the Russell Microcap ® Index ...
RANCHO CORDOVA, Calif., June 12, 2017-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Xiaochun“ Chris” ...
Categories: Yahoo FinanceGet free summary analysis Cesca Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cesca Therapeutics, Inc. – Haemonetics Corporation, Cerus Corporation, Stryker Corporation, Cytori Therapeutics, Inc. and Span-America Medical Systems, Inc. (HAE-US, CERS-US, SYK-US, CYTX-US and SPAN-US) that have also reported ... Read more (Read more...)